Abstract
Objectives
The purpose of this study was to determine whether intravoxel incoherent motion (IVIM) –derived parameters and apparent diffusion coefficient (ADC) could act as imaging biomarkers for predicting antifungal treatment response.
Methods
Forty-six consecutive patients (mean age, 33.9 ± 13.0 y) with newly diagnosed invasive fungal infection (IFI) in the lung according to EORTC/MSG criteria were prospectively enrolled. All patients underwent diffusion-weighted magnetic resonance (MR) imaging at 3.0 T using 11 b values (0-1000 sec/mm2). ADC, pseudodiffusion coffiecient D*, perfusion fraction f, and the diffusion coefficient D were compared between patients with favourable (n=32) and unfavourable response (n=14).
Results
f values were significantly lower in the unfavourable response group (12.6%±4.4%) than in the favourable response group (30.2%±8.6%) (Z=4.989, P<0.001). However, the ADC, D, and D* were not significantly different between the two groups (P>0.05). Receiver operating characteristic curve analyses showed f to be a significant predictor for differentiation, with a sensitivity of 93.8% and a specificity of 92.9%.
Conclusions
IVIM-MRI is potentially useful in the prediction of antifungal treatment response to patients with IFI in the lung. Our results indicate that a low perfusion fraction f may be a noninvasive imaging biomarker for unfavourable response.
Key Points
• Recognition of IFI indicating clinical outcome is important for treatment decision-making.
• IVIM can reflect diffusion and perfusion information of IFI lesions separately.
• Perfusion characteristics of IFI lesions could help differentiate treatment response.
• An initial low f may predict unfavourable response in IFI.
Similar content being viewed by others
Abbreviations
- IFI:
-
invasive fungal infection
- DWI:
-
diffusion-weighted imaging
- ADC:
-
apparent diffusion coefficient
- IVIM:
-
intravoxel incoherent motion
- SNR:
-
signal-to-noise ratio
- D:
-
pure diffusion
- D*:
-
pseudodiffusion coefficient
- f:
-
perfusion fraction
- ROI:
-
region of interest
- ROC:
-
receiver operating characteristic
- ICC:
-
interclass correlation coefficient
- AUC:
-
area under the ROC curve
References
Karthaus M, Buchheidt D (2013) Invasive aspergillosis: new insights into disease, diagnostic and treatment. Curr Pharm Des 19:3569–3594
Maschmeyer G, Haas A, Cornely OA (2007) Invasive aspergillosis: epidemiology, diagnosis and management in immunocompromised patients. Drugs 67:1567–1601
Martin-Pena A, Aguilar-Guisado M, Espigado I, Cisneros JM (2014) Antifungal combination therapy for invasive aspergillosis. Clin Infect Dis 59:1437–1445
Walsh TJ, Anaissie EJ, Denning DW et al (2008) Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America. Clin Infect Dis 46:327–360
Enoch DA, Ludlam HA, Brown NM (2006) Invasive fungal infections: a review of epidemiology and management options. J Med Microbiol 55:809–818
Almyroudis NG, Kontoyiannis DP, Sepkowitz KA et al (2006) Issues related to the design and interpretation of clinical trials of salvage therapy for invasive mold infection. Clin Infect Dis 43:1449–1455
Hahn-Ast C, Glasmacher A, Muckter S et al (2010) Overall survival and fungal infection-related mortality in patients with invasive fungal infection and neutropenia after myelosuppressive chemotherapy in a tertiary care centre from 1995 to 2006. J Antimicrob Chemother 65:761–768
Bernard A, Caillot D, Couaillier JF et al (1997) Surgical management of invasive pulmonary aspergillosis in neutropenic patients. Ann Thorac Surg 64:1441–1447
White NS, McDonald C, Farid N et al (2014) Diffusion-weighted imaging in cancer: physical foundations and applications of restriction spectrum imaging. Cancer Res 74:4638–4652
Le Bihan D, Breton E, Lallemand D et al (1986) MR imaging of intravoxel incoherent motions: application to diffusion and perfusion in neurologic disorders. Radiology 161:401–407
Le Bihan D (2012) Diffusion, confusion and functional MRI. Neuroimage 62:1131–1136
Joo I, Lee JM, Han JK, Choi BI (2014) Intravoxel incoherent motion diffusion-weighted MR imaging for monitoring the therapeutic efficacy of the vascular disrupting agent CKD-516 in rabbit VX2 liver tumors. Radiology 272:417–426
Hauser T, Essig M, Jensen A et al (2014) Prediction of treatment response in head and neck carcinomas using IVIM-DWI: Evaluation of lymph node metastasis. Eur J Radiol 83:783–787
Sieren JC, Ohno Y, Koyama H, Sugimura K, McLennan G (2010) Recent technological and application developments in computed tomography and magnetic resonance imaging for improved pulmonary nodule detection and lung cancer staging. J Magn Reson Imaging 32:1353–1369
Wang LL, Lin J, Liu K et al (2014) Intravoxel incoherent motion diffusion-weighted MR imaging in differentiation of lung cancer from obstructive lung consolidation: comparison and correlation with pharmacokinetic analysis from dynamic contrast-enhanced MR imaging. Eur Radiol 24:1914–1922
Carinci F, Meyer C, Phys D et al (2015) Blood volume fraction imaging of the human lung using intravoxel incoherent motion. J Magn Reson Imaging 41:1454–1464
De Pauw B, Walsh TJ, Donnelly JP et al (2008) Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis 46:1813–1821
Hauser T, Essig M, Jensen A et al (2013) Characterization and therapy monitoring of head and neck carcinomas using diffusion-imaging-based intravoxel incoherent motion parameters-preliminary results. Neuroradiology 55:527–536
Deng Y, Li XC, Lei YX, Liang CH, Liu ZY (2015) Use of diffusion-weighted magnetic resonance imaging to distinguish between lung cancer and focal inflammatory lesions: a comparison of intravoxel incoherent motion derived parameters and apparent diffusion coefficient. Acta Radiol. doi:10.1177/0284185115586091
Lee EY, Yu X, Chu MM et al (2014) Perfusion and diffusion characteristics of cervical cancer based on intraxovel incoherent motion MR imaging-a pilot study. Eur Radiol 24:1506–1513
Freifeld AG, Bow EJ, Sepkowitz KA et al (2011) Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases society of America. Clin Infect Dis 52:56–93
Denning DW, Ribaud P, Milpied N et al (2002) Efficacy and safety of voriconazole in the treatment of acute invasive aspergillosis. Clin Infect Dis 34:563–571
Yan C, Tan X, Wei Q et al (2015) Lung MRI of invasive fungal infection at 3 Tesla: evaluation of five different pulse sequences and comparison with multidetector computed tomography (MDCT). Eur Radiol 25:550–557
Lim C, Seo JB, Park SY et al (2012) Analysis of initial and follow-up CT findings in patients with invasive pulmonary aspergillosis after solid organ transplantation. Clin Radiol 67:1179–1186
Doblas S, Wagner M, Leitao HS et al (2013) Determination of malignancy and characterization of hepatic tumor type with diffusion-weighted magnetic resonance imaging: comparison of apparent diffusion coefficient and intravoxel incoherent motion-derived measurements. Invest Radiol 48:722–728
Pang Y, Turkbey B, Bernardo M et al (2013) Intravoxel incoherent motion MR imaging for prostate cancer: an evaluation of perfusion fraction and diffusion coefficient derived from different b-value combinations. Magn Reson Med 69:553–562
Zhang Z, Yuan Q, Zhou H et al (2015) Assessment of tumor response to oxygen challenge using quantitative diffusion MRI in an animal model. J Magn Reson Imaging. doi:10.1002/jmri.24914
Le Bihan D, Breton E, Lallemand D et al (1988) Separation of diffusion and perfusion in intravoxel incoherent motion MR imaging. Radiology 168:497–505
Smith JA, Kauffman CA (2012) Pulmonary fungal infections. Respirology 17:913–926
Zhang SX, Jia QJ, Zhang ZP et al (2014) Intravoxel incoherent motion MRI: emerging applications for nasopharyngeal carcinoma at the primary site. Eur Radiol 24:1998–2004
Yamada I, Aung W, Himeno Y, Nakagawa T, Shibuya H (1999) Diffusion coefficients in abdominal organs and hepatic lesions: evaluation with intravoxel incoherent motion echo-planar MR imaging. Radiology 210:617–623
Hwang EJ, Lee JM, Yoon JH et al (2014) Intravoxel incoherent motion diffusion-weighted imaging of pancreatic neuroendocrine tumors: prediction of the histologic grade using pure diffusion coefficient and tumor size. Invest Radiol 49:396–402
Bisdas S, Koh TS, Roder C et al (2013) Intravoxel incoherent motion diffusion-weighted MR imaging of gliomas: feasibility of the method and initial results. Neuroradiology 55:1189–1196
Yuan M, Zhang YD, Zhu C et al (2015) Comparison of intravoxel incoherent motion diffusion- weighted MR imaging with dynamic contrast -enhanced MRI for differentiating lung cancer from benign solitay pulmonary lesions. J Magn Reson Imaging. doi:10.1002/jmri.25018
Acknowledgments
We thank Yingjie Mei, at Philips Healthcare, for providing the technical support. The scientific guarantor of this publication is Prof. Yikai Xu. The authors of this manuscript declare relationships with the following companies: Philips Electronics Ltd. One co-author (Queenie Chan) is an employee of Philips Electronics Hong Kong Ltd. Dr. Chan contributed to designing the study, the establishment of the radiology project, and editing and revising the manuscript. The authors state that this work has not received any funding. Prof. Jiyuan Zhou kindly provided statistical advice for this manuscript. Institutional Review Board approval was obtained. Written informed consent was obtained from all subjects (patients) in this study. None of the study subjects or cohorts have been previously reported. Methodology: prospective, diagnostic study, performed at one institution.
Author information
Authors and Affiliations
Corresponding author
Additional information
Chenggong Yan and Jun Xu contributed equally to this work.
Rights and permissions
About this article
Cite this article
Yan, C., Xu, J., Xiong, W. et al. Use of intravoxel incoherent motion diffusion-weighted MR imaging for assessment of treatment response to invasive fungal infection in the lung. Eur Radiol 27, 212–221 (2017). https://doi.org/10.1007/s00330-016-4380-9
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00330-016-4380-9